39 completed, 9 unknown, 3 withdrawn, 2 terminated. 19 Phase 3, 14 Phase 4, 7 Phase 2, 5 Phase 1, 4 Not applicable.
Follow olmesartan: new trials by email Literature Review of olmesartan trials Research Report on olmesartan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Multi-Omics to Predict the Blood Pressure Response to Antihypertensives Amlodipine, Olmesartan, Hydrochlorothiazide - Primary Hypertension | Phase 4 | Unknown | Radboud University Medical Center | 96 | 2024-04-04 | 2024-06-10 |
| Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg) - Hypertension, Hypertension,Essential | Phase 3 | Unknown | Brainfarma Industria Química e Farmacêutica S/A | 400 | 2022-08-01 | 2022-03-21 |
| Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) Indapamide, Amlodipine, Olmesartan - Hypertension | Phase 2 | Completed | Alnylam Pharmaceuticals | 663 | 2021-11-05 | 2025-11-03 |
| Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers Olmesartan, Dapagliflozin - Healthy Adult Volunteers | Phase 1 | Completed | Autotelicbio | 38 | 2021-03-30 | 2021-09-05 |
| Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty sacubitril/valsartan, Angiotensin II Receptor Blockers - Heart Failure, Systolic, Frailty | Unknown | Brigham and Women's Hospital | 40000 | 2021-01-14 | 2021-02-15 | |
| Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension Olmesartan - Angiotensin/Renin/Aldosterone Hypertension, Hypertension | Phase 4 | Completed | Seoul National University Bundang Hospital | 80 | 2021-01-01 | 2023-08-14 |
| Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? Losartan, Valsartan, Azilsartan - Covid19, SARS-CoV Infection | Phase 3 | Terminated | University of British Columbia | 341 | 2020-10-09 | 2023-02-16 |
| Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease Angiotensin Receptor Blockers, Placebo - Coronavirus Disease 2019, COVID-19 | Phase 4 | Completed | The George Institute | 787 | 2020-06-19 | 2022-03-17 |
| Coronavirus (COVID-19) ACEi/ARB Investigation Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19 | Phase 4 | Suspended | National University of Ireland, Galway, Ireland | 2414 | 2020-04-30 | 2020-06-30 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug), Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug), Amlodipine/Olmesartan 10/40mg (Combination drug) - Hypertension, Dyslipidemia | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 237 | 2019-11-20 | 2019-11-13 |
| Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab OLOMAX 20/5/5mg, OLOMAX 20/5/10mg, Olmesartan 20 mg/Amlodipine 5 mg - Hypertension, Dyslipidemias | Phase 4 | Completed | Daewoong Pharmaceutical Co. LTD. | 106 | 2019-08-26 | 2024-07-01 |
| Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke Olmesartan, Nebivolol, No antihypertensive treatment - Stroke, Ischemic | Phase 2 | Completed | Aristotle University Of Thessaloniki | 60 | 2018-08-20 | 2020-01-07 |
| MRA and ARB Treatment in Screening of Primary Aldosteronism canrenone 50-100 mg orally once a day, olmesartan 10-20 mg orally once a day - Primary Aldosteronism Due to Aldosterone Producing Adenoma | Completed | University Hospital Padova | 50 | 2018-01-01 | 2019-12-04 | |
| Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin), Sevikar and Crestor - Healthy | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | 64 | 2017-12-22 | 2018-11-28 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40 mg, Rosuvastatin 20mg, Amlodipine/Olmesartan 10/40mg (Combination drug) - Hypertension, Hyperlipidemias | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 265 | 2017-01-01 | 2022-01-11 |
| Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination)), Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin) - Hypertension, Dyslipidemias | Phase 4 | Completed | Yonsei University | 150 | 2016-05-24 | 2019-08-21 |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam - Community-acquired Pneumonia, Influenza, COVID-19 | Phase 3 | Recruiting | UMC Utrecht | 20000 | 2016-04-11 | 2024-07-12 |
| Study of DWJ1351 in Healthy Male Volunteers DWJ1351, Co-administration of Sevikar (Olmesartan/Amlodipine) and Crestor (Rosuvastatin) - Healthy | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 58 | 2016-01-01 | 2016-01-28 |
Showing 20 of 56. Sign in to see all of them.
Hypertension (28) · Essential Hypertension (11) · Cardiovascular Diseases (5) · COVID-19 (4) · Dyslipidemias (4) · Diabetes Mellitus, Type 2 (3) · Coronavirus Infections (2) · Renal Insufficiency, Chronic (2) · Acute Kidney Injury (1) · Albuminuria (1) · Angina, Unstable (1) · Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · Community-Acquired Pneumonia (1) · Diabetes Mellitus (1)
Daewoong Pharmaceutical Co. LTD. (7) · Novartis Pharmaceuticals (6) · Takeda (4) · EMS (2) · Institut für Pharmakologie und Präventive Medizin (2) · National Taiwan University Hospital (2) · University of Vigo (2) · Yonsei University (2) · AHEPA University Hospital (1) · Alnylam Pharmaceuticals (1) · Aristotle University Of Thessaloniki (1) · Atrial Fibrillation Network (1) · Autotelicbio (1) · Bayer (1) · Baylor Research Institute (1)
South Korea (15) · United States (12) · Germany (7) · Spain (7) · Japan (6) · Taiwan (6) · Argentina (5) · France (4) · Italy (4) · Philippines (4) · Australia (3) · Canada (3) · Colombia (3) · Greece (3) · Hong Kong (3)
Ramon C Hermida, PhD (2) · Adam P Bress, PharmD, MS (1) · Andreas Goette, MD (1) · Colin McArthur, Dr (1) · Dae Hyun Kim, MD, MPH, ScD (1) · Derek Angus, Prof (1) · Eleni Georgianou, MD (1) · Gian Paolo Rossi (1) · Henry Krum, MBBS FRACP PhD (1) · Hyeon-Cheol Gwon, PhD (1) · Inho Chae (1)
PMID 21282560, PMID 17161262, PMID 18539224, PMID 19407805, PMID 21272195, PMID 21586342, PMID 21617110, PMID 21884956, PMID 22157519, PMID 24016511, PMID 24293132, PMID 24351885, PMID 24496699, PMID 26399404, PMID 26934393, PMID 27221952, PMID 30007283, PMID 30518805, PMID 31641769, PMID 31687205, PMID 32267771, PMID 32876697, PMID 33012283, PMID 33394942, PMID 33509275, PMID 33631065, PMID 33778551, PMID 33891615, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34454580, PMID 34473343, PMID 34606578, PMID 35315874, PMID 35477480, PMID 36384746, PMID 36899369, PMID 36942550, PMID 36967714, PMID 37026551, PMID 37039790, PMID 37489818, PMID 37814541, PMID 37877585, PMID 37888913, PMID 38682786, PMID 39325643, PMID 40261382, PMID 40360262
2023 (2), 2009 (1), 2015 (1), K23DK070715 (1), UL1RR025008 (1)